Sarepta Therapeutics, Inc. · NASDAQ:SRPT
State Street Corp reported a 5.40% stake in Sarepta Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 10, 2025
State Street Corp reported a 5.40% stake in Sarepta Therapeutics, Inc., 5,304,907 shares, as a passive investor on Sep 30, 2025. Filed Nov 10, 2025 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 5,304,907
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.40% | 5,304,907 |
Source
Related
- Sarepta Therapeutics, Inc.
- State Street Corp
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026